%0 Journal Article
%T Stenting versus medical treatment for idiopathic intracranial hypertension: a matched-control study.
%A Raynald 
%A Yang H
%A Tong X
%A Huo X
%A Li X
%A Liu L
%A Sui B
%A Qu H
%A Dong K
%A Wang Y
%A Wang S
%A Miao Z
%A Mo D
%J J Neurointerv Surg
%V 15
%N 10
%D Oct 2023 6
%M 36202600
%F 8.572
%R 10.1136/jnis-2022-019191
%X <B>BACKGROUND: </B>This prospective cohort study compared the outcomes of stenting and medical treatment for patients with idiopathic intracranial hypertension (IIH) and venous sinus stenosis (VSS).<BR><B>METHODS: </B>In this single-center cohort study, patients with IIH and VSS were evaluated between January 2014 and December 2019 with follow-up periods of 1, 3, and 6 months. The patients received either stenting or medical treatment. The two groups underwent 1:1 matching using propensity score analysis, and the clinical outcomes were compared.<BR><B>RESULTS: </B>Following 1:1 matching, 36 patients who underwent stenting and 36 who underwent medical treatment were matched. The median improvements in the papilledema Frisén grade were greater in the stenting group at 1 month (-2 vs 0), 3 months (-3 vs -1), and 6 months (-3 vs -1) than in the medical treatment group. Patients who received stenting treatment had a significantly higher prevalence of complete resolution of their respective symptoms (headache, tinnitus, or visual disturbances) at 3 months (58.3% vs 13.9%, OR 8.68, 95% CI 2.74 to 27.52) and 6 months (80.6% vs 22.2%, OR 14.50, 95% CI 4.64 to 45.32) than those receiving medical treatment.<BR><B>CONCLUSIONS: </B>This matched-control study shows that stenting has a greater efficacy rate and rapid resolution of papilledema and its respective symptoms compared with medical treatment.